Dexcom (DXCM) Net Cash Flow (2010 - 2026)
Dexcom (DXCM) posted quarterly Net Cash Flow of -$8.3 million for Q2 2026, down 103.49% year-over-year from $237.7 million in Q2 2025, and down 104.11% quarter-over-quarter from $202.1 million in Q1 2026.
Dexcom (DXCM) Net Cash Flow (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Net Cash Flow for 17 consecutive years, with -$8.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Cash Flow fell 103.49% year-over-year to -$8.3 million; the TTM figure through Jun 2026 stood at -$50.1 million (down 124.61% YoY), while the FY2025 annual figure was $290.3 million, up 515.04% from the prior year.
- Net Cash Flow retreated to -$8.3 million in Q2 2026 per DXCM's latest filing, from $202.1 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $677.7 million in Q3 2025 and bottomed at -$921.6 million in Q4 2025.
- Historically, Net Cash Flow has averaged $2.8 million across 5 years, with a median of -$6.1 million in 2024.
- Annual changes were most pronounced in 2023 — Net Cash Flow jumped 2331.78% — and 2025, when it sank 23530.77%.
- Dexcom's Net Cash Flow stood at -$62.6 million in 2022, then tumbled by 33.23% to -$83.4 million in 2023, then jumped by 95.32% to -$3.9 million in 2024, then tumbled by 23530.77% to -$921.6 million in 2025, then jumped by 99.1% to -$8.3 million in 2026.
- Business Quant data shows DXCM's Net Cash Flow at -$8.3 million in Q2 2026, $202.1 million in Q1 2026, and -$921.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -1.70 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 527.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -892.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 458.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -8.30 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -183.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -926.40 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | -14.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.30 Mn |
| Jun 30, 2026 | -8.30 Mn |
| Mar 31, 2026 | 202.10 Mn |
| Mar 31, 2026 | 202.10 Mn |
| Dec 31, 2025 | -921.60 Mn |
| Dec 31, 2025 | -921.60 Mn |
| Sep 30, 2025 | 677.70 Mn |
| Sep 30, 2025 | 677.70 Mn |
| Jun 30, 2025 | 237.70 Mn |
| Jun 30, 2025 | 237.70 Mn |
| Mar 31, 2025 | 296.50 Mn |
| Mar 31, 2025 | 296.50 Mn |
| Dec 31, 2024 | -3.90 Mn |
| Dec 31, 2024 | -3.90 Mn |
| Sep 30, 2024 | -326.70 Mn |
| Sep 30, 2024 | -326.70 Mn |
| Jun 30, 2024 | 89.10 Mn |
| Jun 30, 2024 | 89.10 Mn |
| Mar 31, 2024 | 288.70 Mn |
| Mar 31, 2024 | 288.70 Mn |